Investigating how certain immune cells affect cancer growth
Follicular Regulatory T-cells Promote Cancer
This study is looking at how certain immune cells called follicular regulatory T-cells affect cancer growth, especially in melanoma, to find new ways to help the body fight tumors better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10993082 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of follicular regulatory T-cells in cancer progression. By examining how these immune cells interact with other immune components, the study aims to uncover mechanisms that tumors use to evade the immune system. The researchers will analyze the behavior of these cells in various cancers, including melanoma, to identify potential therapeutic targets. This could lead to new strategies for enhancing anti-tumor immunity and improving cancer treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancers such as melanoma who are seeking innovative treatment options.
Not a fit: Patients with non-cancerous conditions or those whose cancers are not influenced by immune mechanisms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer immunotherapies that enhance the body's ability to fight tumors.
How similar studies have performed: Previous research has shown promising results in targeting immune cells to improve cancer treatment, suggesting that this approach could be effective.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Leavenworth, Jianmei Wu — University of Alabama at Birmingham
- Study coordinator: Leavenworth, Jianmei Wu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.